Abiraterone acetate, an efficacy treatment option for metastatic castration-resistant prostate carcinoma (mCRPC) that improves functional status in elderly patients (EP)

Saved in:
Bibliographic Details
Published in:Journal of geriatric oncology 2012-10, Vol.3, p.S85-S85
Main Authors: Fratino, L, Re, G. Lo, Polesel, J, Channoufi, L, Muggia, M, Depangher, V, Bearz, A, Spina, M, Tirelli, U
Format: Article
Language:English
Subjects:
Hematology, Oncology and Palliative Medicine
Internal Medicine
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1879-4068
1879-4076
DOI:10.1016/j.jgo.2012.10.103